Steve Krognes - CFO and Treasurer, Denali Therapeutics Inc
As of February 15, 2022
Steve Krognes Net Worth
- Net worth is estimated to be at least $46.04M
- Owns at least 970,221 units of Denali Therapeutics Inc stock
- Sold an estimated value of $10.72M in the last 5 years at Denali Therapeutics Inc
Steve Krognes Compensation at Denali Therapeutics Inc in 2020
- Earned a $484,200 salary and a $387 bonus
- Rewarded $1,364,638 in stock value and options
- Received a total compensation of $4,266,044
Steve Krognes Trading
- Largest sale of shares was 50,000 units , worth over $3.57M on January 20, 2021
- In total has made about 20 transactions over 5 years
- Usually trades in February, with the busiest year in 2021
Steve Krognes
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Steve Krognes Mailing Address
- Mailing address is 863 Mitten Road, Suite 102 Burlingame CA 94010 CA
Denali Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Ryan J. Watts, Ph.D. | 2020 | $589,472 | $648,419 | $2,596,305 | $5,456,849 | $11,400 | $9,302,445 |
| Ryan J. Watts, Ph.D. | 2019 | $566,800 | $311,740 | $838,168 | $3,252,452 | $9,447 | $4,978,607 |
| Ryan J. Watts, Ph.D. | 2018 | $545,000 | $524,563 | $ | $4,914,360 | $ | $5,983,923 |
| Alexander O. Schuth, M.D. | 2020 | $449,400 | $359,520 | $1,364,638 | $2,018,444 | $11,400 | $4,203,402 |
| Alexander O. Schuth, M.D. | 2019 | $428,000 | $171,200 | $305,830 | $1,558,941 | $12,657 | $2,476,628 |
| Alexander O. Schuth, M.D. | 2018 | $400,000 | $355,000 | $179,673 | $2,948,616 | $18,500 | $3,901,789 |
| Steve E. Krognes | 2020 | $484,200 | $387,362 | $1,364,638 | $2,018,444 | $11,400 | $4,266,044 |
| Steve E. Krognes | 2019 | $470,057 | $188,023 | $305,830 | $1,558,941 | $7,834 | $2,530,685 |
| Steve E. Krognes | 2018 | $455,260 | $393,682 | $179,673 | $2,948,616 | $24,000 | $4,001,231 |
| Carole Ho, M.D. | 2020 | $457,600 | $366,080 | $1,382,774 | $2,107,493 | $11,400 | $4,325,347 |
| Carole Ho, M.D. | 2019 | $440,000 | $176,000 | $305,830 | $1,558,941 | $8,800 | $2,489,571 |
| Carole Ho, M.D. | 2018 | $423,124 | $371,187 | $179,673 | $2,948,616 | $12,869 | $3,935,469 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm
Denali Therapeutics Inc Insider Trading
- The most recent transaction was 20,000 units sold on March 25, 2022 by Marc Tessierlavigne worth over $676.58K
- In the last 5 years, insiders at Denali Therapeutics Inc sold an estimated value of $436.02M and bought an estimated value of $7.95M
- The most active traders are Alexander Schuth, COO and Secretary, Ryan Watts, President and CEO, and Carole Ho, Chief Medical Officer
- Insider trading is most common in June, with the busiest year in 2021
Denali Therapeutics Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||